SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report:
SEPTEMBER 17, 1999
CHESAPEAKE BIOLOGICAL LABORATORIES, INC.
-------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
MARYLAND 1-12748 52-1176514
----------------------- ----------------------- -------------
(State of Incorporation) (Commission File Number) (IRS Employer
Identification No.)
1111 South Paca Street
BALTIMORE, MARYLAND 21230
---------------------------------------------------
(Address of principal executive offices) (Zip Code)
(410) 843-5000
-------------------------------
(Registrant's telephone number)
Item 5. OTHER EVENTS.
Effective September 14, 1999, all of the holders of the Company's
Series A Convertible Preferred Stock exchanged their shares for a like number of
shares of the Company's Series A-1 Convertible Preferred Stock. The terms of the
Series A-1 Convertible Preferred Stock are identical to the Series A Convertible
Preferred Stock except for the following items:
- dividends will be paid beginning on May 31, 2001 rather than May 31,
2000;
- Series A-1 Convertible Preferred Stock does not carry Dividend
Warrants (as defined in the Articles Supplementary filed with the May
24, 1999 8-K); and
- If the Company fails to redeem the Series A-1 Convertible Preferred
Stock by May 31, 2004, the Series A-1 Convertible Preferred Stock will
carry additional cash dividends at an annual rate of 20%.
Item 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
EXHIBIT NO. DESCRIPTION
------------ -------------
3.01 Articles Supplementary
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: September 17, 1999 CHESAPEAKE BIOLOGICAL LABORATORIES, INC.
By: /s/ Thomas P Rice
-------------------------------------
Thomas P. Rice, President and CEO
-2-
CHESAPEAKE BIOLOGICAL LABORATORIES, INC.
FORM 8-K
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION
------------ -------------
3.01 Articles Supplementary
-3-